Executive Interview: Gitte Aabo On Leo Pharma's Innovation Strategy

The head of Denmark's multinational specialty dermatology company has unveiled a strategy to the year 2025 that includes a large increase in R&D spending, a continued interest in bulking up its established products business, and improving its commercial presence in Latin America and other markets.